Vertex Pharmaceuticals Incorporated (LON:0QZU)
London · Delayed Price · Currency is GBP · Price in USD 468.61
+11.77 (2.58%)
Jan 22, 2026, 5:06 PM GMT
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 87.09 billion as of January 22, 2026. Its market cap has increased by 3.12% in one year.
Market Cap
87.09B
Enterprise Value
79.52B
Revenue
8.72B
Ranking
n/a
PE Ratio
31.85
Stock Price
468.61
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 87.09B, an increase of 169,959.63%. That is a compound annual growth rate of 24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 83.30B | -2.53% |
| Dec 31, 2025 | 85.46B | 3.17% |
| Dec 31, 2024 | 82.84B | 0.64% |
| Dec 29, 2023 | 82.31B | 33.80% |
| Dec 30, 2022 | 61.52B | 49.20% |
| Dec 31, 2021 | 41.23B | -8.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |